Drug Trial Radar · NCT06749457
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
242
Actual
Start
Dec 30, 2024
Primary completion
Mar 8, 2027
Study completion Dec 13, 2027
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Parexel
- First posted
- Dec 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous catheter (Phase IIa).
Conditions
- Staphylococcus Aureus
Interventions
AZD7760Drug
Participants will receive AZD7760 as a single intravenous infusion.
PlaceboOther
Participants will be administered placebo through intravenous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase I: Occurence of adverse events (AEs)Time frame: Day 1 to Day 181
- Phase I: Occurence of medically-attended adverse events (MAAEs), serious adverse events (SAEs), and adverse events of special interest (AESIs)Time frame: Day 1 to Day 361
- Phase IIa: Occurrence of AEs, MAAEs, SAEs, and AESIsTime frame: Day 1 to Day 181
Locations
40 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Huntsville, Alabama
Research Site
Chula Vista, California
Research Site
Glendale, California
Research Site
Granada Hills, California
Research Site
Los Angeles, California
Research Site
Northridge, California
Research Site
Northridge, California
Research Site
Oxnard, California
Research Site
Riverside, California
Research Site
San Dimas, California
Research Site
Tarzana, California
Research Site
Valencia, California
Research Site
Victorville, California
Research Site
Englewood, Colorado
Research Site
Bradenton, Florida
Research Site
Coral Springs, Florida
Research Site
Hollywood, Florida
Research Site
Orlando, Florida
Research Site
Tampa, Florida
Research Site
Lawrenceville, Georgia
Research Site
Chicago, Illinois
Research Site
Chicago, Illinois
Research Site
Iowa City, Iowa
Research Site
Lexington, Kentucky
Research Site
Baltimore, Maryland
Research Site
Detroit, Michigan
Research Site
Pontiac, Michigan
Research Site
Tupelo, Mississippi
Research Site
Kansas City, Missouri
Research Site
Lincoln, Nebraska
Research Site
Las Vegas, Nevada
Research Site
Jersey City, New Jersey
Research Site
Albuquerque, New Mexico
Research Site
Ridgewood, New York
Research Site
Winston-Salem, North Carolina
Research Site
Bethlehem, Pennsylvania
Research Site
Beaumont, Texas
Research Site
Dallas, Texas
Research Site
Houston, Texas
Research Site
McAllen, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.